For-profit dialysis centers tend to administer Amgen Inc.’s anemia drugs at higher than recommended levels, potentially raising the risk for deadly side effects, according to a study funded by the U.S ...

CHICAGO, March 12 (Reuters) - DaVita Inc. , the biggest provider of dialysis in the United States, saw its shares fall more than 3 percent on Monday after it warned of a possibility that safety ...

Failure to administer epogen substantially increases the risk of death, according to court papers.“We see a lot of Medicaid fraud but this is unusual,” Bardos said yesterday.

Hospira, Inc. HSP presented data from two studies on a proposed biosimilar, Retacrit (Epoetin Hospira), at the National Kidney Foundation spring meeting. The drug is a proposed biosimilar to Amgen Inc ...